Collaboration on
innovative products
·PB-119GLP-1R
·PB-718GLP-1R/GCGR
·PB-2301GLP-1R/GIPR
·PB-2309GLP-1R/GIPR/GCGR
·PB-1902μ opioid receptor
·PB-722GCGR
Collaboration on
technical platform
We have established a Highly Effective Target Screening & Molecule Modifier Platform (HECTOR®). Through HECTOR®, we leverage our sophisticated experience in drug molecular design and turn our in-depth understanding of unmet medical needs and target mechanisms in the field of metabolic diseases into drug candidates with ompetitive edge for subsequent development.
We are open for
Licensing
Co-development
Option deal
M&A
Others